University of Leeds spin-out Tissue joined the Alternative Investment Market in June 2010 through the reverse takeover of listed Oxeco.
Tissue Regenix, a UK-listed healthcare company spun out of the University of Leeds, is trying to raise £25m ($35m) through a share placing. The university retains 5.2% of Tissue ahead of the placing after the company was incorporated in May 2006 to commercialise the academic research of its professors, Eileen Ingham and John Fisher. Tissue…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
